Expertise in
39
conditions

Dr. Matthew T. Wheeler

Advanced Heart Failure and Transplant Cardiology | Cardiology
300 Pasteur Dr, 
Stanford, CA 
Offers Telehealth
Expertise in
39
conditions
300 Pasteur Dr, 
Stanford, CA 

Overview

Matthew Wheeler is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist practicing medicine in Stanford, California.

Dr. Wheeler is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Dilated Cardiomyopathy (DCM), Subvalvular Aortic Stenosis, and Heart Transplant.

He is actively involved in clinical research, co-authoring 245 peer reviewed articles and participating in 6 clinical trials.

Specialties

Advanced Heart Failure and Transplant Cardiology
Cardiology

Licenses

Internal Medicine in CA

Hospital Affiliations

Stanford Health Care Tri-Valley
Peninsula Medical Center
Stanford Health Care

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Health Plan of San Mateo
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
HMSA
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Santa Clara Family Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Sutter Health
  • HMO
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 17 Less Insurance Carriers -

Locations

STANFORD HEALTH CARE
300 Pasteur Dr, Stanford, CA 94305
Other Locations
STANFORD HEALTH CARE
5800 Hollis St, Emeryville, CA 94608
STANFORD HEALTH CARE
2585 Samaritan Dr, San Jose, CA 95124

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Precision Medicine for Dilated Cardiomyopathy in European and African Ancestry
Precision Medicine for Dilated Cardiomyopathy in European and African Ancestry
Enrollment Status: Active_not_recruiting
Publish Date: July 30, 2025
Intervention Type: Behavioral
Study Phase: Not Applicable
A Phase 3, Multinational, Randomized, Placebo-controlled Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation (REALM-DCM)
A Phase 3, Multinational, Randomized, Placebo-controlled Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation (REALM-DCM)
Enrollment Status: Terminated
Publish Date: January 09, 2024
Intervention Type: Other, Drug
Study Drug: ARRY-371797 (PF-07265803)
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study to Assess the Safety and Tolerability of JK07 in Subjects With Heart Failure With Preserved Ejection Fraction (HFpEF)
A Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Study to Assess the Safety and Tolerability of JK07 in Subjects With Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Withdrawn
Publish Date: May 31, 2023
Intervention Type: Drug
Study Phase: Phase 1
A Randomized, Double-blind, Placebo-controlled, Concentration-guided, Exploratory Study of Mavacameten in Patients With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) and Preserved Left Ventricular Ejection Fraction
A Randomized, Double-blind, Placebo-controlled, Concentration-guided, Exploratory Study of Mavacameten in Patients With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM) and Preserved Left Ventricular Ejection Fraction
Enrollment Status: Completed
Publish Date: August 09, 2022
Intervention Type: Drug
Study Phase: Phase 2
A Randomized, Double Blind, Placebo Controlled Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
A Randomized, Double Blind, Placebo Controlled Clinical Study to Evaluate Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Enrollment Status: Completed
Publish Date: October 04, 2021
Intervention Type: Drug
Study Phase: Phase 3
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Enrollment Status: Completed
Publish Date: January 11, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

240 Total Publications

The effect of sex and endurance exercise training on the incretin signaling pathway in 17 rat tissues.
The effect of sex and endurance exercise training on the incretin signaling pathway in 17 rat tissues.
Journal: Physiological genomics
Published: August 24, 2026
Similar Doctors
Expertise in
30
conditions
Dr. Ronald M. Witteles
Advanced Heart Failure and Transplant Cardiology | Cardiology
Expertise in
30
conditions
Dr. Ronald M. Witteles
Advanced Heart Failure and Transplant Cardiology | Cardiology
Referral may be required

Stanford Health Care

300 Pasteur Dr, 
Stanford, CA 
 (0.1 miles away)
650-723-4000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ronald Witteles is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist practicing medicine in Stanford, California. Dr. Witteles is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Primary Amyloidosis, Transthyretin Amyloid Cardiomyopathy, Cardiomyopathy, Heart Transplant, and Cardiac Ablation.

Expertise in
26
conditions
Dr. Kiran K. Khush
Advanced Heart Failure and Transplant Cardiology | Cardiology
Expertise in
26
conditions
Dr. Kiran K. Khush
Advanced Heart Failure and Transplant Cardiology | Cardiology
Referral may be required

Stanford Health Care

300 Pasteur Dr, 
Stanford, CA 
 (0.1 miles away)
650-723-4000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kiran Khush is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist practicing medicine in Stanford, California. Dr. Khush is highly rated in 26 conditions, according to our data. Her clinical expertise encompasses Arrhythmias, Atrial Fibrillation, Heart Failure, Brugada Syndrome, and Heart Transplant.

Expertise in
58
conditions
Dr. Francois F. Haddad
Advanced Heart Failure and Transplant Cardiology | Cardiology
Expertise in
58
conditions
Dr. Francois F. Haddad
Advanced Heart Failure and Transplant Cardiology | Cardiology
Referral may be required

Stanford Health Care

5800 Hollis St, 
Emeryville, CA 
 (28.8 miles away)
510-806-2100
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Francois Haddad is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist practicing medicine in Emeryville, California. Dr. Haddad is highly rated in 58 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Cardiomyopathy, Dilated Cardiomyopathy (DCM), Heart Transplant, and Embolectomy.

Frequently Asked Questions about Dr. Matthew T. Wheeler

How do I make an appointment with Dr. Matthew T. Wheeler?

You can book an appointment with Dr. Matthew T. Wheeler by calling their office at 650-723-4000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Matthew T. Wheeler a top-rated expert for Cardiomyopathy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Matthew T. Wheeler is classified as an Elite expert for Cardiomyopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Matthew T. Wheeler specialize in?

While Dr. Matthew T. Wheeler is a Advanced Heart Failure and Transplant Cardiology, they have specific expertise in Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), and Dilated Cardiomyopathy (DCM). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Advanced Heart Failure and Transplant Cardiology.

Does Dr. Matthew T. Wheeler participate in research or clinical trials?

Yes. Dr. Matthew T. Wheeler has published 240 articles and abstracts on conditions like Cardiomyopathy. You can view a list of Dr. Matthew T. Wheeler's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Matthew T. Wheeler accept my insurance?

Dr. Matthew T. Wheeler accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 650-723-4000 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Wheeler's expertise for a condition
ConditionClose
View All 9 Distinguished Conditions
View All 27 Advanced Conditions
View All 44 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile